Cost-effectiveness analysis of treatments to reduce cholesterol concentration, blood pressure and smoking for the prevention of coronary heart disease

被引：0
|
作者：
Plans-Rubió, P [1 ]
机构：
[1] Dept Sanitat Catalonia SCS, Barcelona, Spain
来源：
VALUE IN HEALTH | 2002年 / 5卷 / 06期
关键词：
D O I：
10.1016/S1098-3015(10)61288-0
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：484 / 484
页数：1
相关论文
共 50 条
  • [21] COST-EFFECTIVENESS OF BLOOD CHOLESTEROL MEASUREMENTS IN PRIMARY PREVENTION OF ARTERIOSCLEROSIS
    ANIA, BJ
    MEDICINA CLINICA, 1990, 95 (08): : 317 - 318
  • [22] Cost-Effectiveness of Treatments Reducing Coronary Heart Disease Mortality in Ireland, 2000 to 2010
    Bennett, Kathleen
    Kabir, Zubair
    Barry, Michael
    Tilson, Lesley
    Fidan, Dogan
    Shelley, Emer
    Capewell, Simon
    VALUE IN HEALTH, 2009, 12 (01) : 10 - 15
  • [23] Cost-effectiveness of lovastatin, cholestyramine and gemfibrozil for the primary prevention of coronary heart disease through cholesterol reduction in Catalonia, Spain
    Plans-Rubió, P
    Rovira, J
    VALUE IN HEALTH, 2003, 6 (06) : 630 - 630
  • [24] EVALUATING PRIMARY PREVENTION OF CORONARY HEART-DISEASE USING TOTAL CHOLESTEROL UNDERESTIMATES THE COST-EFFECTIVENESS OF LIPID CHANGES
    KINOSIAN, B
    GLICK, H
    SCHULMAN, K
    JUHN, P
    JACOBSON, T
    EISENBERG, J
    CLINICAL RESEARCH, 1992, 40 (02): : A585 - A585
  • [25] A COST-EFFECTIVENESS ANALYSIS OF ALTERNATIVE STRATEGIES FOR THE PREVENTION OF HEART-DISEASE
    HALL, J
    HELLER, R
    DOBSON, A
    LLOYD, D
    SANSONFISHER, R
    LEEDER, S
    COMMUNITY HEALTH STUDIES, 1986, 10 (03): : 373 - 373
  • [26] A COST-EFFECTIVENESS ANALYSIS OF ALTERNATIVE STRATEGIES FOR THE PREVENTION OF HEART-DISEASE
    HALL, JP
    HELLER, RF
    DOBSON, AJ
    LLOYD, DM
    SANSONFISHER, RW
    LEEDER, SR
    MEDICAL JOURNAL OF AUSTRALIA, 1988, 148 (06) : 271 - 277
  • [27] Lipid-Lowering Strategies for Primary Prevention of Coronary Heart Disease in the UK: A Cost-Effectiveness Analysis
    Morton, Jedidiah I. Z. I.
    Marquina, Clara
    Lloyd, Melanie
    Watts, Gerald F. F.
    Zoungas, Sophia
    Liew, Danny
    Ademi, Zanfina
    PHARMACOECONOMICS, 2024, 42 (01) : 91 - 107
  • [28] Lipid-Lowering Strategies for Primary Prevention of Coronary Heart Disease in the UK: A Cost-Effectiveness Analysis
    Jedidiah I. Morton
    Clara Marquina
    Melanie Lloyd
    Gerald F. Watts
    Sophia Zoungas
    Danny Liew
    Zanfina Ademi
    PharmacoEconomics, 2024, 42 : 91 - 107
  • [29] PRIMARY PREVENTION OF CORONARY HEART-DISEASE IN THE FEDERAL-REPUBLIC-OF-GERMANY ANALYSIS OF COST-EFFECTIVENESS
    ASSMANN, G
    SCHULTE, H
    DRUGS, 1990, 40 : 33 - 37
  • [30] Prevention of coronary heart disease with aspirin and clopidogrel: efficacy, safety, costs and cost-effectiveness
    Ho, WK
    Hankey, GJ
    Eikelboom, JW
    EXPERT OPINION ON PHARMACOTHERAPY, 2004, 5 (03) : 493 - 503
12345